Nektar Therapeutics (MM) Stock Price - NKTR

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$43.59
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
Big Cap Pro
Monthly Subscription
for only
$40.31
VAT not included
After Hours
Last Trade
Last: $ 23.93 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN
Nektar Therapeutics (MM) NKTR NASDAQ Common Stock US6402681083
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.55 +2.35% 23.93 24.05 23.14 23.35 23.38 20:00:00
Bid Price Ask Price Spread Spread % News
22.76 29.50 6.74 22.85% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10,301 1,746,840 $ 23.7629 $ 41.51M 1.62M 11.41 - 24.05
Last Trade Time Type Quantity Stock Price Currency
19:51:15 formt 200 $23.93 USD

Nektar Therapeutics (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.68B 153.83M $ -153.52M -1.10 0.00 72.29M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.09M $ 0.00 0.00% 186.39k 95.00%

more financials information »

Nektar Therapeutics (MM) News

Date Time Source News Article
3/27/201709:00PR Newswire (US)Nektar Therapeutics Initiates Clinical Study of NKTR-358, a..
3/22/201718:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
3/20/201707:38Edgar (US Regulatory)Current Report Filing (8-k)
3/20/201707:30PR Newswire (US)NKTR-181 Meets Primary and Secondary Endpoints in Phase 3..
3/17/201718:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
3/16/201718:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
3/02/201719:01PR Newswire (US)Nektar to Webcast Presentation at Cowen and Company's 37th..

Historical NKTR Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week21.9524.0521.500.00002M9M4M1.989.02%
1 Month13.7724.0512.500.0000766k15M3M10.1673.78%
3 Months12.4824.0511.410.0000648k15M2M11.4591.75%
6 Months18.5524.0511.410.0000387k15M2M5.3829.00%
1 Year12.5724.0511.410.0000368k15M1M11.3690.37%
3 Years12.1624.059.160.0000015M1M11.7796.79%
5 Years7.7924.055.650.0000015M1M16.14207.19%

Nektar Therapeutics (MM) Description

Nektar Therapeutics, Inc, is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170329 03:25:33